key: cord-0999461-dknpdgwn authors: Glavin, Diarmuid; Kelly, Denise; Wood, Greta Karen; McCausland, Beth MS; Ellul, Mark Alexander; Varatharaj, Aravinthan; Galea, Ian; Thomas, Rhys Huw; Michael, Benedict Daniel; Gallen, Brian title: COVID-19 encephalitis with SARS-CoV-2 detected in cerebrospinal fluid presenting as a stroke mimic date: 2021-05-31 journal: J Stroke Cerebrovasc Dis DOI: 10.1016/j.jstrokecerebrovasdis.2021.105915 sha: 839ee8afd8e186d525caddd5285c2fd95d6493f8 doc_id: 999461 cord_uid: dknpdgwn We report the case of a 35-year-old male with COVID-19 encephalitis presenting as a stroke mimic with sudden-onset expressive and receptive dysphasia, mild confusion and right arm incoordination. The patient received thrombolysis for a suspected ischaemic stroke, but later became febrile and SARS-CoV-2 was detected in cerebrospinal fluid. Electroencephalography demonstrated excess in slow waves, but neuroimaging was reported as normal. Respiratory symptoms were absent throughout and nasopharyngeal swab was negative for SARS-CoV-2. At the most recent follow-up, the patient had made a full neurological recovery. Clinicians should therefore consider testing for SARS-CoV-2 in CSF in patients who present with acute focal neurology, confusion and fever during the pandemic, even when there is no evidence of respiratory infection. The neurological complications associated with COVID-19 remain under investigation, with cerebrovascular disease at the forefront of debate [1] . This case demonstrates the complexities faced characterising neurological pathology during the SARS-CoV-2 pandemic, with real-world clinical implications. Case A 35-year-old male presented with sudden-onset expressive and receptive dysphasia, mild confusion and right arm incoordination (National Institutes of Health Stroke Scale: 5). The patient had a medical history of migraines only, no regular medication and was a current smoker. Initial CT brain (Fig. 1A) showed no significant intracranial abnormalities and the patient received thrombolysis for a suspected ischaemic stroke. Symptoms resolved over 2 hours and post-thrombolysis CT (day 2, Fig. 1B ) was reported as normal. Respiratory symptoms were absent, and admission nasopharyngeal swab was negative for SARS-CoV-2. On day 3, the patient had right arm weakness and later developed expressive and receptive dysphasia, amnesia, headache and vomiting, followed by pyrexia 39.7 °C. GCS remained 15/15 without evidence of meningism. MRI brain (day 3, Fig. 1C ,D) was normal. Serum antibody testing did not detect anti-SARS-CoV-2 antibodies. The differentiation of strokes and stroke mimics is a particular challenge in COVID-19 patients. Limited stroke risk factors, new seizures, acute or subacute encephalopathy and reduced GCS could suggest a stroke mimic [1] . Whilst several reports have speculated upon the diagnosis of encephalitis in COVID-19 patients, [2] [3] [4] detection of SARS-CoV-2 in CSF remains rare [5] [6] [7] . Two main plausible routes of entry for SARS-CoV-2 to the central nervous system (CNS) are via the angiotensinconverting enzyme 2 receptors located on epithelial cells of the blood-cerebrospinal fluid barrier and via retrograde axonal transport of peripheral neural pathways such as via the olfactory mucosa in the nasal cavity [8] . Evidence of CSF pleocytosis with white cell count >100 x10 6 /L is suggestive of CNS infection and is clear evidence of CSF inflammation [9] . Numerous other CNS and systemic infections were excluded on culture and PCR. Non-infectious causes were excluded with brain imaging (CT, MRI and MRA brain). There are several potential reasons for negative nasopharyngeal PCR tests including reduced viral load, transient viral dissemination or collection and storage errors. Research has shown a median false negative rate of COVID-19 nasopharyngeal RT-PCR of 38% on the day of symptom onset and maximum COVID-19 replication in the throat seen 5 days after symptom onset [10] [11] . Clinicians should therefore consider testing for SARS-CoV-2 in CSF in patients who present with acute focal neurology, confusion and fever during the pandemic, even when there is no evidence of respiratory infection. The patient gave consent for publication of his case in the medical literature. Neurological Associations of COVID-19 Meningoencephalitis without Respiratory Failure in a Young Female Patient with COVID-19 Infection in Downtown Los Angeles Encephalitis as a Clinical Manifestation of COVID-19. Brain, Behav Immun 2020 Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 Nervous system involvement after infection with COVID-19 and other coronaviruses SARS-CoV-2 Detected in Cerebrospinal Fluid by PCR in a Case of COVID-19 Encephalitis Virus infections in the nervous system Cerebrospinal fluid pleocytosis level as a diagnostic predictor? A cross-sectional study Real-time RT-PCR in COVID-19 detection: issues affecting the results Reducing False Negative PCR Test for COVID-19 We would like to acknowledge the Regional Virus Laboratory, Royal Victoria Hospital, Belfast for the diagnostics performed.